Centerbridge Partners L.P. continued to hold its position in American Renal Associates Holdings, Inc (NYSE:ARA) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,615,836 shares of the company’s stock at the end of the 2nd quarter. American Renal Associates Holdings makes up approximately 32.4% of Centerbridge Partners L.P.’s investment portfolio, making the stock its biggest position. Centerbridge Partners L.P. owned about 56.31% of American Renal Associates Holdings worth $326,774,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Teachers Advisors LLC increased its stake in American Renal Associates Holdings by 42.6% during the fourth quarter. Teachers Advisors LLC now owns 20,092 shares of the company’s stock valued at $428,000 after acquiring an additional 6,000 shares during the period. Oxford Asset Management acquired a new position in American Renal Associates Holdings in the 1st quarter valued at approximately $237,000. Martingale Asset Management L P acquired a new position in American Renal Associates Holdings in the 1st quarter valued at approximately $372,000. FMR LLC raised its holdings in American Renal Associates Holdings by 14.3% in the 1st quarter. FMR LLC now owns 3,989,578 shares of the company’s stock valued at $67,344,000 after acquiring an additional 500,624 shares in the last quarter. Finally, TimesSquare Capital Management LLC raised its holdings in American Renal Associates Holdings by 3.6% in the 1st quarter. TimesSquare Capital Management LLC now owns 1,209,550 shares of the company’s stock valued at $20,417,000 after acquiring an additional 41,500 shares in the last quarter. 89.92% of the stock is currently owned by institutional investors and hedge funds.

Separately, Zacks Investment Research downgraded American Renal Associates Holdings from a “buy” rating to a “hold” rating in a research report on Wednesday, July 12th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. American Renal Associates Holdings currently has a consensus rating of “Hold” and a consensus price target of $22.33.

WARNING: “Centerbridge Partners L.P. Maintains Position in American Renal Associates Holdings, Inc (ARA)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another domain, it was illegally copied and republished in violation of international trademark & copyright law. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/10/02/centerbridge-partners-l-p-maintains-position-in-american-renal-associates-holdings-inc-ara.html.

American Renal Associates Holdings, Inc (ARA) traded up 1.07% during midday trading on Monday, reaching $15.13. 18,365 shares of the company’s stock were exchanged. The company has a 50 day moving average price of $14.81 and a 200 day moving average price of $14.81. The company’s market cap is $473.34 million. American Renal Associates Holdings, Inc has a 12 month low of $14.23 and a 12 month high of $24.94.

American Renal Associates Holdings (NYSE:ARA) last issued its quarterly earnings results on Tuesday, August 8th. The company reported $0.16 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.12 by $0.04. The company had revenue of $185.99 million during the quarter, compared to the consensus estimate of $188.23 million. American Renal Associates Holdings had a negative net margin of 1.54% and a positive return on equity of 18.25%. The business’s revenue for the quarter was up .2% on a year-over-year basis. On average, equities analysts anticipate that American Renal Associates Holdings, Inc will post $0.54 EPS for the current year.

American Renal Associates Holdings Company Profile

American Renal Associates Holdings, Inc is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia.

Institutional Ownership by Quarter for American Renal Associates Holdings (NYSE:ARA)

Receive News & Stock Ratings for American Renal Associates Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates Holdings Inc and related stocks with our FREE daily email newsletter.